Quarter Financials

Iovance Biotherapeutics, Inc. (IOVA)

$16.79

+0.88 (+5.53%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Net Income -114-107-104-102-99-99-92-99
Dividend Paid --------
Retained Earnings -1,896-1,782-1,676-1,568-1,463-1,363-1,264-1,172

PPE Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Capital Expenditure -4-10-6-3-1-5-11-8
Net PPE 179180180178169172176170

Intangible and Goodwill Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
New Purchases -142-46-40-64-96-5210-93
Intangible and Goodwill --------